GlassScriptPhysician profile
Raymond L Singer
NPI 1407807456
$7,961.69
in general payments reported to CMS, 2019-2025
23 companies · $876 in 2025
The $876 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,296 · 2020: $28.45 · 2021: $601 · 2022: $340 · 2023: $815 · 2024: $1,005 · 2025: $876.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,696.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,618.15 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $2,298.93 | 2019-2024 | Navitor |
| Abiomed | $492.52 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $389.56 | 2019-2025 | Mitris Resilia Mitral Valve |
| Aop Health US, LLC | $218.90 | 2025 | Rapiblyk |
| Baxter Healthcare | $193.45 | 2019-2023 | Preveleak |
| Bolton Medical INC | $141.87 | 2024 | Treo Abdominal Stent-Graft System |
| Cook Medical LLC | $133.97 | 2023 | Cook |
| Livanova USA, INC. | $65.87 | 2022-2023 | Lifesparc |
| Zimmer Biomet Holdings, INC. | $58.86 | 2019-2022 | |
| Ethicon US, LLC | $45.13 | 2019-2025 | Evarrest, Prolene |
| Philips North America LLC | $42.28 | 2023-2024 | (Ck4) Mcot |
| Solventum Corporation | $38.16 | 2025 | Prevena |
| Janssen Biotech, INC. | $34.92 | 2019 | |
| La Jolla Pharmaceutical Company | $34.91 | 2024 | Giapreza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paladin Technology Solutions | $28.22 | 2024 | |
| Biom'Up Sa | $27.43 | 2019 | |
| Biomerieux INC | $24.70 | 2019 | |
| Covidien LP | $21.82 | 2019 | |
| Medtronic, INC. | $18.50 | 2025 | Corevalve Evolut R |
| Getinge USA Sales, LLC | $18.02 | 2019 | |
| Angiodynamics, INC. | $15.52 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.